Physician profile
Amanda Pong
NPI 1750583399
$9,601.59
in general payments reported to CMS, 2019-2025
37 companies · $1,458 in 2025
The $1,458 reported for 2025 was more than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $238 · 2022: $1,656 · 2023: $2,307 · 2024: $3,944 · 2025: $1,458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,923 · Travel and Lodging: $1,769 · Education: $16.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,922.51 |
| Travel and Lodging | $1,769.15 |
| Education | $16.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,980.74 | 2021-2025 | Fintepla, Briviact, Nayzilam |
| H. Lundbeck A S | $1,510.73 | 2024 | |
| Livanova USA, INC. | $862.25 | 2022-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Sk Life Science, INC. | $635.74 | 2021-2025 | |
| Neurelis, INC. | $474.26 | 2022-2025 | Valtoco |
| Jazz Pharmaceuticals INC. | $402.41 | 2021-2025 | Epidiolex |
| Sunovion Pharmaceuticals INC. | $297.19 | 2021-2022 | |
| Kyowa Kirin, INC. | $277.85 | 2021-2024 | Nourianz |
| Sumitomo Pharma America, INC. | $261.91 | 2023-2024 | Aptiom |
| Argenx US, INC. | $260.56 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Biocodex, INC. | $246.10 | 2021-2025 | |
| Eisai INC. | $211.74 | 2021-2023 | |
| Lilly USA, LLC | $202.35 | 2021-2024 | Emgality, Reyvow |
| Immedica Pharma US, INC. | $185.77 | 2022-2024 | |
| Axsome Therapeutics, INC. | $137.91 | 2023-2025 | Sunosi |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Pong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.